These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 18959471)

  • 1. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
    Remedi MS; Nichols CG
    PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonylurea and glinide reduce insulin content, functional expression of K(ATP) channels, and accelerate apoptotic beta-cell death in the chronic phase.
    Takahashi A; Nagashima K; Hamasaki A; Kuwamura N; Kawasaki Y; Ikeda H; Yamada Y; Inagaki N; Seino Y
    Diabetes Res Clin Pract; 2007 Sep; 77(3):343-50. PubMed ID: 17316868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
    Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P
    Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinsulinism in mice with heterozygous loss of K(ATP) channels.
    Remedi MS; Rocheleau JV; Tong A; Patton BL; McDaniel ML; Piston DW; Koster JC; Nichols CG
    Diabetologia; 2006 Oct; 49(10):2368-78. PubMed ID: 16924481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
    Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
    J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
    Pearson ER; Flechtner I; Njølstad PR; Malecki MT; Flanagan SE; Larkin B; Ashcroft FM; Klimes I; Codner E; Iotova V; Slingerland AS; Shield J; Robert JJ; Holst JJ; Clark PM; Ellard S; Søvik O; Polak M; Hattersley AT;
    N Engl J Med; 2006 Aug; 355(5):467-77. PubMed ID: 16885550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
    Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
    J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.
    Muñoz A; Hu M; Hussain K; Bryan J; Aguilar-Bryan L; Rajan AS
    Endocrinology; 2005 Dec; 146(12):5514-21. PubMed ID: 16123162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired glucose-stimulated insulin secretion and reduced β-cell mass in pancreatic islets of hyperthyroid rats.
    Karbalaei N; Noorafshan A; Hoshmandi E
    Exp Physiol; 2016 Aug; 101(8):1114-27. PubMed ID: 27060234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
    Flechtner I; de Lonlay P; Polak M
    Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonylurea induced beta-cell apoptosis in cultured human islets.
    Maedler K; Carr RD; Bosco D; Zuellig RA; Berney T; Donath MY
    J Clin Endocrinol Metab; 2005 Jan; 90(1):501-6. PubMed ID: 15483097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-cell hyperexcitability: from hyperinsulinism to diabetes.
    Nichols CG; Koster JC; Remedi MS
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():81-8. PubMed ID: 17919182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misunderstandings and controversies about the insulin-secreting properties of antidiabetic sulfonylureas.
    Henquin JC
    Biochimie; 2017 Dec; 143():3-9. PubMed ID: 28711685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
    Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
    Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic exposure to tolbutamide and glibenclamide impairs insulin secretion but not transcription of K(ATP) channel components.
    Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
    Pharmacol Res; 2004 Jul; 50(1):41-6. PubMed ID: 15082027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin stimulus-secretion coupling is triggered by a novel thiazolidinedione/sulfonylurea hybrid in rat pancreatic islets.
    Mendes CP; Postal BG; Oliveira GTC; Castro AJG; Frederico MJS; Moraes ALL; Neuenfeldt PD; Nunes RJ; Menegaz D; Silva FRMB
    J Cell Physiol; 2018 Jan; 234(1):509-520. PubMed ID: 29968920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells.
    Miura A; Yamagata K; Kakei M; Hatakeyama H; Takahashi N; Fukui K; Nammo T; Yoneda K; Inoue Y; Sladek FM; Magnuson MA; Kasai H; Miyagawa J; Gonzalez FJ; Shimomura I
    J Biol Chem; 2006 Feb; 281(8):5246-57. PubMed ID: 16377800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of Action of Novel Glibenclamide Derivatives on Potassium and Calcium Channels for Insulin Secretion.
    Frederico MJS; Castro AJG; Menegaz D; Murat CB; Mendes CP; Mascarello A; Nunes RJ; Silva FRMB
    Curr Drug Targets; 2017; 18(6):641-650. PubMed ID: 27316908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.
    Sawada F; Inoguchi T; Tsubouchi H; Sasaki S; Fujii M; Maeda Y; Morinaga H; Nomura M; Kobayashi K; Takayanagi R
    Metabolism; 2008 Aug; 57(8):1038-45. PubMed ID: 18640379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.